Alnylam Pharmaceuticals' IPO

Alnylam Pharmaceuticals raised a round of funding on May 28, 2004. Investors include Public.

Alnylam Pharmaceuticals (NASDAQ: ALNY) is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company believes that are many new therapeutic frontiers fo…

Articles about Alnylam Pharmaceuticals' IPO: